Dataset: Detailed transcriptomics analysis of the effect of dietary fatty acids on gene regulation in the murine heart.
Fatty acids comprise the primary energy source for the heart and are mainly taken up via hydrolysis of circulating triglyceride-rich...
Fatty acids comprise the primary energy source for the heart and are mainly taken up via hydrolysis of circulating triglyceride-rich lipoproteins. While most of the fatty acids entering the cardiomyocyte are oxidized, a small portion is involved in altering gene transcription to modulate cardiometabolic functions. So far, no in vivo model has been developed enabling study of the transcriptional effects of specific fatty acids in the intact heart. In the present study, mice were given a single oral dose of synthetic triglycerides composed of one single fatty acid. Hearts were collected 6h thereafter and used for whole genome gene expression profiling. Experiments were conducted in wild-type and PPARα−/− mice to allow exploration of the specific contribution of PPARα. It was found that: 1) linolenic acid (C18:3) had the most pronounced effect on cardiac gene expression. 2) The largest similarity in gene regulation was observed between linoleic acid (C18:2) and C18:3. Large similarity was also observed between the synthetic PPARα agonist Wy14643 and docosahexaenoic acid (C22:6). 3) Many genes were regulated by one particular treatment only. Genes regulated by one particular treatment showed large functional divergence. 4) The majority of genes responding to fatty acid treatment were regulated in a PPARα-dependent manner, emphasizing the importance of PPARα in mediating transcriptional regulation by fatty acids in the heart. 5) Several genes were robustly regulated by all or many of the fatty acids studied, mostly representing well-described targets of PPARs (e.g. Acot1, Angptl4, Ucp3). 6) Deletion and activation of PPARα had a major effect on expression of numerous genes involved in metabolism and immunity. Our analysis demonstrates the marked impact of dietary fatty acids on gene regulation in the heart via PPARα. To study the transcriptional effects of specific fatty acids in the intact heart, wild type and PPARα−/− mice were given a single oral dose of 4 synthetic triglycerides composed of one single fatty acid, as well as of the synthetic PPARα agonist Wy14,643. Hearts were collected 6h after gavag and used for whole genome gene expression profiling.
- Species:
- mouse
- Samples:
- 55
- Source:
- E-GEOD-30495
- PubMed:
- 22274564
- Updated:
- Dec.12, 2014
- Registered:
- Nov.11, 2014
Sample | GENOTYPE | TREATMENT |
---|---|---|
GSM756426 | 129S1/SvImJ | none |
GSM756426 | 129S1/SvImJ | none |
GSM756426 | 129S1/SvImJ | none |
GSM756429 | 129S1/SvImJ | trilinolenin |
GSM756429 | 129S1/SvImJ | trilinolenin |
GSM756429 | 129S1/SvImJ | trilinolenin |
GSM756429 | 129S1/SvImJ | trilinolenin |
GSM756433 | 129S1/SvImJ | trilinolein |
GSM756433 | 129S1/SvImJ | trilinolein |
GSM756433 | 129S1/SvImJ | trilinolein |
GSM756433 | 129S1/SvImJ | trilinolein |
GSM756433 | 129S1/SvImJ | trilinolein |
GSM756438 | 129S1/SvImJ | triolein |
GSM756438 | 129S1/SvImJ | triolein |
GSM756438 | 129S1/SvImJ | triolein |
GSM756438 | 129S1/SvImJ | triolein |
GSM756442 | 129S1/SvImJ | tridocosahexaenoin |
GSM756442 | 129S1/SvImJ | tridocosahexaenoin |
GSM756442 | 129S1/SvImJ | tridocosahexaenoin |
GSM756442 | 129S1/SvImJ | tridocosahexaenoin |
GSM756442 | 129S1/SvImJ | tridocosahexaenoin |
GSM756447 | 129S1/SvImJ | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756447 | 129S1/SvImJ | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756447 | 129S1/SvImJ | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756447 | 129S1/SvImJ | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM75645 | PPARalpha -/- (129S4/SvJae) | none |
GSM75645 | PPARalpha -/- (129S4/SvJae) | none |
GSM75645 | PPARalpha -/- (129S4/SvJae) | none |
GSM75645 | PPARalpha -/- (129S4/SvJae) | none |
GSM75645 | PPARalpha -/- (129S4/SvJae) | none |
GSM756456 | PPARalpha -/- (129S4/SvJae) | trilinolenin |
GSM756456 | PPARalpha -/- (129S4/SvJae) | trilinolenin |
GSM756456 | PPARalpha -/- (129S4/SvJae) | trilinolenin |
GSM756456 | PPARalpha -/- (129S4/SvJae) | trilinolenin |
GSM756456 | PPARalpha -/- (129S4/SvJae) | trilinolenin |
GSM75646 | PPARalpha -/- (129S4/SvJae) | trilinolein |
GSM75646 | PPARalpha -/- (129S4/SvJae) | trilinolein |
GSM75646 | PPARalpha -/- (129S4/SvJae) | trilinolein |
GSM75646 | PPARalpha -/- (129S4/SvJae) | trilinolein |
GSM75646 | PPARalpha -/- (129S4/SvJae) | trilinolein |
GSM756466 | PPARalpha -/- (129S4/SvJae) | triolein |
GSM756466 | PPARalpha -/- (129S4/SvJae) | triolein |
GSM756466 | PPARalpha -/- (129S4/SvJae) | triolein |
GSM756466 | PPARalpha -/- (129S4/SvJae) | triolein |
GSM756466 | PPARalpha -/- (129S4/SvJae) | triolein |
GSM75647 | PPARalpha -/- (129S4/SvJae) | tridocosahexaenoin |
GSM75647 | PPARalpha -/- (129S4/SvJae) | tridocosahexaenoin |
GSM75647 | PPARalpha -/- (129S4/SvJae) | tridocosahexaenoin |
GSM75647 | PPARalpha -/- (129S4/SvJae) | tridocosahexaenoin |
GSM75647 | PPARalpha -/- (129S4/SvJae) | tridocosahexaenoin |
GSM756476 | PPARalpha -/- (129S4/SvJae) | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756476 | PPARalpha -/- (129S4/SvJae) | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756476 | PPARalpha -/- (129S4/SvJae) | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756476 | PPARalpha -/- (129S4/SvJae) | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |
GSM756476 | PPARalpha -/- (129S4/SvJae) | Wy14,643 (aka pirinixic acid) is a synthetic PPARalpha agonist. CAS Number: 50892-23-4 |